Skip to main content
. 2020 Jul 2;12(7):1770. doi: 10.3390/cancers12071770

Table 5.

Outcomes of FIGO 2018 Stage IIIC1r patients with squamous cell carcinoma of the uterine cervix stratified by tumor T stage.

T Stage 5-Year OS 5-Year PFS
T1b 100.0 (NA–NA) 100.0 (NA–NA)
T2 82.5 (59.7–93.0) 65.6 (42.8–81.1)
T3 65.2 (45.4–79.2) 54.7 (36.0–70.0)

FIGO, International Federation of Gynecology and Obstetrics. OS, overall survival; PFS, progression-free survival; NA, not assessable. Data are % (95% confidence intervals).